Abstract
Recognized since 1883 as a common cause of infection, Staphylococcus aureus’ preantimicrobial-era bacteremia mortality rate was 82%. The mortality of that era threatens to return as evidence of growing vancomycin resistance undermines the utility of vancomycin therapy. Successful treatment of S. aureus infections requires knowledge of its antimicrobial resistance capacity.
Smith TL, Jarvis WR
Microbes Infect. 1999 Aug;1(10):795-805
PMID: 10816085